Homeotic genes code for key transcription factors (HOX--TFs) that pattern the animal body 38 plan. During embryonic development, Hox genes are expressed in overlapping patterns and 39 function in a partially redundant manner. In vitro biochemical screens probing the HOX--TF 40 sequence specificity revealed largely overlapping sequence preferences, indicating that co--41 factors might modulate the biological function of HOX--TFs. However, due to their 42 overlapping expression pattern, high protein homology, and insufficiently specific 43 antibodies, little is known about their genome--wide binding preferences. In order to 44 overcome this problem, we virally expressed tagged versions of limb--expressed posterior 45 Hox genes (Hoxa9--13, and Hoxd9--13) in primary mesenchymal limb progenitor cells 46 (micromass). We determined the effect of each HOX--TF on cellular differentiation 47 52 Group 2: HOXA/D11 and HOXD13), which are characterized by differences in their sequence 53 specificity and by the presence of cofactor motifs. Specifically, we identified CTCF binding 54 sites in Group 1, indicating that this subgroup of HOX--proteins cooperates with CTCF. We 55 confirmed this interaction by an independent biological assay (proximity ligation assay) and 56 showed that CTCF is a novel HOX cofactor that specifically associates with Group 1 HOX--TFs, 57 pointing towards a possible interplay between HOX--TFs and chromatin architecture. 58 59
(chondrogenesis) and gene expression and found that groups of HOX--TFs induce distinct 48 regulatory programs. We used ChIP--seq to determine their individual genome--wide binding 49 profiles and identified between 12,540 and 27,466 binding sites for each of the nine TFs. Principal Component Analysis (PCA) of binding profiles revealed that the HOX--TFs are 51 clustered in two subgroups (Group 1: HOXA/D9, HOXA/D10, HOXD12, and HOXA13 and Introduction 60 The homeotic genes (Hox genes) are key regulators of development. They encode 61 homeodomain transcription factors (HOX--TFs) that are expressed in an overlapping fashion 62 along the anterior--posterior axis in all metazoans (McGinnis and Krumlauf 1992) . In the 63 vertebrate genome, Hox genes are organized in clusters with their order reflecting not only 64 their expression along the anterior--posterior body axis but also their temporal expression 65 (spatio--temporal collinearity). In most vertebrates, two rounds of whole--genome duplication 66 have resulted in four clusters of Hox genes, coding for a total of 39 HOX--TFs. All HOX--TFs 67 show high levels of sequence conservation between paralog groups (e.g. HOXA9 and HOXD9) 68 and to a lesser extent between genes of the same cluster (e.g. HOXA1 to HOXA13) (reviewed 69 in Gehring et al. 2009; Rezsohazy et al. 2015) . 70 In the developing vertebrate limb, the posterior genes of the HoxA and HoxD clusters (HOX9-- Hoxa11 and Hoxd11 causes a severe truncation of the stylopod and loss of the zeugopod 78 (Davis et al. 1995; Raines et al. 2015) . A similar redundancy is observed between genes of 79 the same cluster. Deletions, in mice, that encompass the entire Hoxd13 gene cause the 80 adjacent Hoxd12 to be expressed in a Hoxd13--like pattern associated with the functional 81 rescue of the Hoxd13 deficiency. A similar deletion, removing Hoxd13 and Hoxd12 causes 82 Hoxd11 to be expressed in a Hoxd13--like pattern; however, Hoxd11 is not able to rescue the 83 loss of its two adjacent paralogs (Kmita et al. 2002) . 84 In spite of the insights gained by these elegant series of genetic experiments, the high 85 degree of Hox protein similarity and the overlap of expression domains have hindered the 86 elucidation of the individual HOX--TF functions. HOX--TFs were also included in large 87 biochemical surveys to identify the specific binding sequence of transcription factors (Berger 88 et al. 2008; Jolma et al. 2013; Jolma et al. 2015) . Two complementary studies applying 89 protein binding microarrays (PBM) and SELEX--seq on purified DNA--binding domains 90 demonstrated that all posterior HOX--TFs bind to similar AT--rich sequences that vary in their 91 4 5' region, but share a characteristic TAAA sequence in their 3' half. Moreover, two NMR 92 based studies showed binding of HOXA13 to the HOXD13 site and vice versa (Zhang et al. 93 2011; Turner et al. 2015) . Thus, the DNA binding specificity is not sufficient to explain 94 individual HOX--TF function. More recent studies revealed a crucial role for cofactors in HOX--95 TF specificity. HOX--cofactors were shown to specifically alter the recognition sequence of 96 the HOX--TFs by forming heterodimers (Joshi et al. 2007; Slattery et al. 2011; Jolma et al. 97 2015) . Moreover, the analysis of HOX--cofactor specific binding sites suggested that these 98 altered binding sites might be functionally more relevant for HOX binding than the HOX--TFs 99 binding sites themselves (Crocker et al. 2015) . However, due to high sequence homology, 100 inadequate antibody specificity, and overlapping expression patterns little is known about 101 genomic binding of the different HOX--TFs and how this might relate to their biological 102 function. 103 Here, we have analysed and systematically compared the effects of nine limb bud--expressed 104 HOX--TFs (HOXA9--13 and HOXD9--13) on cell differentiation and gene regulation and compare 105 their genome--wide binding characteristics. To mimic the natural HOX environment as closely 106 as possible, we used mesenchymal chicken limb bud cells and mild retroviral overexpression 107 (Ibrahim et al. 2013) . In this primary cell culture system (chicken micromass, chMM) the cells 108 normally undergo chondrogenic differentiation; a process that can be altered by virally 109 expressed transgenes (Ibrahim et al. 2013) . Given the identical cell origin, culture conditions, 110 and antibody use, this system allowed us to assess the distinctive properties of each HOX--TF 111 and compare them to each other. 112 We find that certain HOXA/HOXD paralog TFs have opposing effects on chondrogenic 113 differentiation and induce distinct regulatory programs in transduced cells. Further, by 114 comparing the genome--wide DNA binding of nine HOX--TFs, in this experimental setting, we 115 find that the posterior HOX--TFs can be separated into two groups (Group 1 and Group 2), 116 with distinct binding motifs and distinct associations with cofactors. Finally, we characterized 117 CTCF (the CCCTC--binding factor) as a novel cofactor of HOX--TFs and show that Group 1 but 118 not Group 2 HOX--TFs bind thousands of CTCF--occupied sites in the chicken genome. the process (HOXD9, HOXD11, HOXA11, HOXD12, HOXA13, and HOXD13) ( Figure 1A ). 130 Interestingly, paralogue HOX--TFs did not always have the same general impact on the 131 chondrogenic differentiation of the chMM. While HOXA9 stimulated chondrogenic 132 differentiation, its paralog HOXD9 inhibited the same process. In contrast, HOXA10 and 133 HOXD10 both promoted chondrogenic differentiation. HOXA11 and HOXD11 both inhibited 134 chondrogenic differentiation, but to a very different extent. Finally, HOXD13 and HOXA13 135 both strongly inhibited cartilage formation; however, Eosin staining showed that the cell 136 morphology of the HOXA13--expressing chMM was quite distinct from HOXD12 or HOXD13 137 cultures ( Figure 1A ). 138 The simple readout of the chMM morphology showed that the HOX--TFs induce distinct 139 effects on cell differentiation. In order to comprehensively compare the effects on gene 140 expression, we performed RNA--seq of HOX--TF expressing chMM cultures. We used DEseq2 141 (Love et al. 2014 ) to generate a list of genes that were differentially regulated compared 142 with mock--infected chMM cultures. We then used the genes that were found among the 50 143 most strongly regulated genes in any of the nine datasets for hierarchical clustering ( Figure   144 1B, Supplemental Table 1 ). 145 The hierarchical clustering recapitulated some of the main differences found between HOX-- 146 TFs that were detected in chMM gross morphology. HOX10 and HOX11 paralogs clustered 147 together, while HOX9 paralogs, which bore striking differences in chMM morphology, 148 clustered apart. Furthermore, the clustering process classified the paralog groups in an order 149 that partially corresponded to their known role in limb development. The clustering 150 separated the stylo--/zeugopod expressed HOX--TFs (HOXD9, HOX10/11) from the autopod 151 expressed HOXD12/13. Two factors, HOXA9 and HOXA13, clustered separately from all other 152 HOX--TFs, indicating that the regulatory programs these factors induce are distinct from the 153 6 other posterior HOX--TFs. Moreover, the HOX11 paralogs induced transcriptional programs 154 so similar to one another that the clustering algorithm was not able to separate the two 155 replicate datasets from each factor. Interestingly, two genes coding for subunits of the AP1 156 class of transcription factors, JUN and FOS, were among the most strongly upregulated 157 genes in all of the datasets, suggesting that they might be direct targets of HOX--TFs. Our Genome--wide binding reveals two distinct groups of HOX--TFs 164 We next wanted to assess whether analogous differences could be observed between 165 paralog groups in their genome--wide binding preferences. We generated ChIP--seq profiles of 166 the virally expressed HOX--TFs in chMM cultures using the αFLAG antibody. We identified 167 between 12,540 and 27,466 binding sites for each of the nine HOX--TFs ( Figure  2 ). We first 168 assessed the binding sites shared between HOX--TFs from the same paralog groups by taking 169 the 10,000 strongest peaks for each factor and then calculated the pairwise overlap between 170 all HOX--TFs. Similar to the results of the expression analysis, the HOX10 and HOX11 paralogs 171 shared more peaks (78--81% and 85--86%, respectively) than the HOX9 and HOX13 paralogs 172 (65--60% and 24--16%) (Supplemental Figure 1A) . 173 Next, we performed a principal components analysis (PCA) to compare the datasets in an 174 unbiased way, using the identified peaks as input ( Figure  2B ). PCA showed that the binding 175 of HOX--TF paralogs seemed to be more similar than their effects on chMM differentiation 176 and gene expression. HOXA13 and HOXD13 were a notable exception as they clustered 177 separately from the other HOX--TFs along PC1 ( Figure 2B , dashed box). In addition, they were 178 also very different from one another in PC2. A comparison of all tested HOX--TFs in PC2 179 revealed a surprising separation into two groups, which neither reflected the effects on cell To find a possible cause for this separation, we first tested whether the grouping could be 184 attributed to the sequence--specificity of the TFs. For this we performed de novo motif 185 analysis using the peak--motifs algorithm (Medina--Rivera et al. 2015) with the 5,000 186 strongest peaks as input and compared it to the published results from PBM and SELEX--seq 187 ( Figure 2C and Supplemental Figure 1B) . This comparison showed a general similarity 188 between in vitro and ChIP--seq derived motifs. However, several sequence features had not 189 been detected in the previously published datasets. We found a prominent G at the 5' end of 190 all Group 1 motifs (HOXA/D9, HOXA/D10, HOXD12, and HOXA13), which had also been 191 detected using SELEX--seq (Jolma et al. 2013 ). More striking, we found that the TAAA 3' end, 192 which is a characteristic of posterior HOX--TFs, changed to a TGAAA in all Group 1 HOX--TFs, 193 with the notable exception of HOXA13. 194 The motifs identified for HOXA13 and HOXD13 were identical to the ones detected in 195 PBM/SELEX--seq. In contrast, the primary motif of HOXA11 and HOXD11 did not overlap with 196 those detected in the corresponding in vitro datasets. Specifically, the CCATAAA motif 197 (HOXA/D11) we observed was highly similar to a change in sequence specificity that HOXA10 198 undergoes when co--binding with PBX4 (Jolma et al. 2015) . Generally, motif analysis for the 199 HOX--TFs identified not only primary motifs, but also several alternative HOX--like motifs, 200 suggesting that the DNA--dependent binding of HOX--TFs might be less sequence--driven than 201 other TFs (Supplemental Figure 1B) . 202 Group 1 (HOXA/D9, HOXA/D10, HOXD12, and HOXA13) and Group 2 (HOXA/D11 and 203 HOXD13) HOX--TFs also revealed differences, when we considered the fraction of ChIP--seq 204 peaks that contained a HOX--TFs binding site ( Figure 2D and Supplemental Figure 1C ). The 205 number of peaks carrying a HOX--binding site (i.e. matching one of the top three HOX motifs) 206 was relatively low in general, ranging from as little as 15% (HOXD9) to 43% (HOXD13). 207 Interestingly, the three Group 2 HOX--TFs had the highest number of HOX binding sites in 208 contrast to the Group 1 HOX--TFs, which displayed the lowest number of peaks carrying HOX 209 binding sites. To exclude the effect of weak and maybe indirect binding sites from the 210 analysis, we performed the same analysis for the 10,000 and 1,000 strongest peaks 211 (Supplemental Figure 1C) . Although the fraction of binding site--containing peaks slightly 212 increased, the general distribution stayed the same. In Group 2 of HOX--TFs, we were not able to detect any clear cofactor motif. In contrast, we 223 found three putative cofactor motifs in five out of the six Group 1 HOX--TF peak sets. The first 224 motif was the well--characterized TGANTCA AP1 binding site (Glover and Harrison 1995) 225 ( Figure  3A) . A second motif, CGCTCCG was detected with high specificity in the HOXA9 and 226 HOXD9 peaks and with lower specificity (but still among the top 5) in the HOXA10, HOXD10 227 and HOXD12 peaks (Supplemental Figure 2A and 2B) . This motif was particularly enriched in 228 HOXA13 peaks (Supplemental Figure 5) . We were not able to find matching or similar motifs Figure  4 ) binding sites in the nine Hox--TF data sets. For the CTCF binding sites, this reverse 239 search revealed a characteristic difference between Group 1 and Group 2 HOX--TFs. 240 Altogether, 12--21% of all Group 1 HOX--TF peaks, but only 4--9% of Group 2 HOX--TF peaks 241 contained a CTCF binding site (Supplemental Figure 3A) . In contrast, we identified AP1 Next, we mapped the position of the CTCF binding sites within the HOX--TF peaks and found 246 that in Group 1, but not Group 2, the CTCF sites were located predominantly near the peak 247 summits ( Figure 3B and Supplemental Figure 3B ), suggesting a binding mode in which the 248 HOX--TF binds indirectly via CTCF. This was further supported by a discriminatory motif 249 analysis, which revealed that Group 1 HOX--TF peaks contained either a HOX or a CTCF 250 binding site and that only a minority of HOX--TF peaks contained binding sites for both TFs 251 ( Figure 3C ).
253
Group 1 HOX--TFs and CTCF/cohesin co--bind genome--wide 254 Motif analysis indicated that CTCF and Group 1 HOX--TFs might co--bind to many sites 255 throughout the genome. We therefore mapped CTCF binding sites genome--wide by virally 256 expressing FLAG--tagged CTCF in chMM cultures (Figure 4) and performed ChIP--seq using the 257 αFLAG antibody. From the same sample, we also performed ChIP--seq for endogenous 258 RAD21, a subunit of the cohesin complex and an important CTCF--cofactor (Faure et al. 2012) . 259 We identified 22,357 CTCF and 17,589 RAD21 binding sites. Similar to previous reports, CTCF 260 and RAD21 co--bound to 53% of all CTCF and to 67% of all RAD21 peaks. We then tested how 261 many HOX--TF peaks overlapped with CTCF or RAD21 peaks. We observed that the 262 characteristic distinction between Group 1 and Group 2 HOX--TFs could be recapitulated at 263 ChIP--seq binding sites. Indeed, Group 1 HOX--TFs shared between 15% and 24% of their 264 peaks with CTCF (12--20% with RAD21), whereas only 3--8% of Group 2 peaks overlapped with 265 CTCF (3--7% with RAD21) ( Figure 4C and Supplemental Figure 6A , B and C). 266 Finally, we investigated the presence of CTCF and HOX binding motifs at shared binding sites 267 with HOXA10 (Group 1) as a representative example. We looked for underlying binding sites 268 in the 24% of HOXA10 peaks that are shared with CTCF and observed that 69% of them 277 Both, motif analysis and peak overlap strongly suggested an interaction between Group 1 278 HOX--TFs and CTCF. To test this possibility, we made use of the proximity ligation assay 279 (PLA) (Soderberg et al. 2006) . The PLA assay allowed us to assess protein--protein interactions 280 in situ, in a quantifiable and sensitive manner. We expressed FLAG--tagged HOXA10 (Group 1) 281 in chicken DF1 cells and performed the PLA assay using αFLAG antibody and an endogenous 282 αCTCF antibody. We readily detected CTCF--HOXA10 interaction in the nucleus that was 283 almost as strong as the interaction of CTCF with RAD21, which we used as a positive control 284 (Figure  4) . We also performed the same assay with CTCF and the Group 2 HOXD13 protein, 285 for which our ChIP--seq data had predicted a weaker interaction. In this case we measured a 286 signal above our negative control (DF1 cells expressing CTCF alone), but less than for the 287 CTCF--HOXA10 interaction ( Figure 4D shown to be biologically more significant (Crocker et al. 2015) . Our analysis also highlights 317 the role cofactors play in directing HOX--TF binding. The primary motif for both HOX11 318 paralogs was in many ways different from the in vitro determined monomer specificity and 319 rather revealed a composite binding site like the one bound by a HOXA10--PBX4 dimer (Jolma 320 et al. 2015) . Furthermore, our data indicate a relationship between HOX--TFs and the AP1 321 class of TFs. AP1 binding sites were found in 5% of all HOX--TF peaks and JUN and FOS were 322 also strongly upregulated by all HOX--TFs, suggesting a mechanism of cofactor cross--323 regulation. To our knowledge, AP1 has not been linked to limb patterning or HOX--TFs. 324 However, these factors are known to be involved in a wide array of developmental and cell 325 differentiation processes (Hess et al. 2004 ) and our results suggest AP1 may potentially have 326 a role in mediating HOX--driven limb patterning. 327 PCA analysis separated the HOX--TF binding sites in two subgroups along PC2. We tried to 328 identify the underlying cause for this distinction between HOX--TF binding sites and found co--329 binding with CTCF to correlate with Group 1 HOX--TF binding. We also describe CTCF as a 
Group 1 HOX--TFs and CTCF interact in the nucleus

